Motus GI

About

Motus GI touted clinical data evaluating its Pure-Vu cleaning system.

Tirat Carmel,Hefa,Israel
1 - 10

Highlights

Details

Last Funding Type: Post-IPO Debt
Last Funding Money Raised: $12M
Industries: Biotechnology,Health Care,Health Diagnostics,Information Technology,Medical Device
Founded date: Jan 1, 2010
Number Of Employee: 1 - 10
Operating Status: Active
Stock Symbol: nasdaq:MOTS
Legal Name: Motus GI Holdings, Inc.

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$67.50M

Motus GI has raised a total of $67.50M in funding over 2 rounds. Their latest funding was raised on Jul 21, 2021 from a Post-IPO Debt round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 21, 2021	Post-IPO Debt	$12M	1	Kreos Capital	—	Detail
Dec 18, 2019	Post-IPO Debt	$8M	1	Silicon Valley Bank	—	Detail
Feb 14, 2018	IPO	$17.50M	—	—	—	Detail
Dec 1, 2016	Series Unknown	$30M	6	Perceptive Advisors	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

8

Motus GI is funded by 8 investors. Kreos Capital and Silicon Valley Bank are the most recent investors.

Investor Name	Lead Investor	Funding Round
Kreos Capital	Yes	Post-IPO Debt
Silicon Valley Bank	Yes	Post-IPO Debt
Perceptive Advisors	Yes	Series Unknown
Ascent Biomedical Ventures	—	Series Unknown
Jacobs Investments, Inc.	—	Series Unknown
Orchestra Medical Ventures	—	Series Unknown
Pura Vida Investments	—	Series Unknown
SternAegis	—	Series Unknown